U.S. Stocks Move | Pharmaceutical Stocks Continue to Rise, AstraZeneca (AZN.US) Surges Over 6% After Earnings

智通财经APP reports that on Friday, US pharmaceutical stocks continued to rise. Eli Lilly (LLY.US) climbed more than 4%, and AstraZeneca (AZN.US) opened sharply higher. As of press time, it was up more than 6%, with a cumulative gain of over 15% in October. In terms of news, AstraZeneca released its third quarter 2026 results. On a constant exchange rate (CER) basis, total revenue for the quarter increased by 7% year-on-year to $16.209 billion. Product sales grew by 5% to $15.066 billion, and alliance revenue increased by 36% to $1.107 billion. Core earnings per share were $2.79, up 19% year-on-year; reported earnings per share were $2.02, up 26%. According to MarketBeat's consensus, the market originally expected core earnings per share of $2.60 and revenue of $16.0 billion for the quarter, both of which were roughly 7% and 1% higher, respectively.